Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 51 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 17 Prostatic Neoplasms 16 Melanoma 15 Neoplastic Cells, Circulating 13 Pancreatic Neoplasms 11 Multiple Myeloma 11 Uterine Cervical Neoplasms 10 Ovarian Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Papillomavirus Infections 7 Neoplasm Metastasis 7 Leukemia, Myeloid, Acute 7 Colonic Neoplasms 7 Lymphoma, Follicular 6 Lymphoma 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Sarcoma 5 Head and Neck Neoplasms 5 Glioma 5 Uterine Cervical Dysplasia 4 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Glioblastoma 4 Disease 4 COVID-19 4

Interventions

Interferon beta-1b 2 Fingolimod Hydrochloride 2 teriflunomide 1 nabiximols 1 Platelet Transfusion 1 OM 89 1 Natalizumab 1 Mn-PyC3A 1 Magnetic Resonance Imaging 1 Interferon beta-1a 1 Fish Oils 1 Dimethyl Fumarate 1 Blood Specimen Collection 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Sclerosis × Blood Specimen Collection × Clear all

NCT04844489 2023-02-06

COVIVAC-ID

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

COVID-19, Multiple Sclerosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡